HIGHLIGHTS
- who: Aditi Hazra and collaborators from the Division of Preventive Medicine, Brigham and Women`s Hospital, Harvard Medical School, Boston, MA, USA have published the research: Copy Number Variation in Inflammatory Breast Cancer, in the Journal: Cells 2023, x of /2023/
- what: The aim of the study was to elucidate biomarkers associated with IBC. The analysis compared the 14 DFCI IBC stage III patients and 388 stage III TCGA non-IBC patients.
- how: The authors conducted principal component analysis (Supplementary Figure S2).
SUMMARY
Mutations, receptor driven gene clusters, differential . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.